Antidepressants in long-term therapy: A review of tricyclic antidepressants and selective serotonin reuptake inhibitors

Acta Psychiatrica Scandinavica, Supplement

Volumn 101, Issue 403, 2000, Pages 35-38

  Hirschfeld, R M A ^a   Judge, R ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Long term; SSRI; TCA

Indexed keywords

FLUOXETINE; IMIPRAMINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG WITHDRAWAL; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REMISSION; FOLLOW UP; REVIEW; TIME;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 0034565204     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects
2. Sertraline in the prevention of depression
3. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness
4. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness
5. Treatment of depression by drugs and psychotherapy
6. Continuation therapy with amitriptyline in depression
7. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression
8. A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression
9. Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction
10. Optimal length of continuation therapy in depression; a prospective assessment during long-term fluoxetine treatment
11. The prophylactic efficacy of fluoxetine in unipolar depression
12. Three-year outcomes for maintenance therapies in recurrent depression
13. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination
14. Five-year outcome for maintenance therapies in recurrent depression
15. Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression